0.52
price down icon10.33%   -0.0698
 
loading
Dbv Technologies Adr stock is traded at $0.52, with a volume of 85,196. It is down -10.33% in the last 24 hours and down -24.99% over the past month. DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body. Its main product candidate is Viaskin Peanut for the treatment of peanut-allergic patients.
See More
Previous Close:
$0.5898
Open:
$0.5898
24h Volume:
85,196
Relative Volume:
0.13
Market Cap:
$56.74M
Revenue:
-
Net Income/Loss:
$-72.73M
P/E Ratio:
-0.9369
EPS:
-0.555
Net Cash Flow:
$-80.33M
1W Performance:
-21.64%
1M Performance:
-24.99%
6M Performance:
-54.68%
1Y Performance:
-69.60%
1-Day Range:
Value
$0.5289
$0.5999
1-Week Range:
Value
$0.5289
$0.6733
52-Week Range:
Value
$0.5024
$2.14

Dbv Technologies Adr Stock (DBVT) Company Profile

Name
Name
Dbv Technologies Adr
Name
Phone
33(0)155427878
Name
Address
107 AVENUE DE LA REPUBLIQUE, CHATILLON
Name
Employee
108
Name
Next Earnings Date
2024-07-29
Name
Latest SEC Filings
Name
DBVT's Discussions on Twitter

Compare DBVT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
DBVT 0.5289 56.74M 0 -72.73M -80.33M -0.555
VRTX 467.19 119.83B 10.63B -479.80M -1.35B 13.33
REGN 760.91 83.28B 13.85B 4.65B 3.32B 35.06
ARGX 566.22 33.74B 1.86B -40.29M -1.28B -4.16
ALNY 230.54 30.38B 2.09B -332.26M 16.06M -4.14
BNTX 101.55 24.08B 3.30B -501.07M 1.03B 11.54

Dbv Technologies Adr Stock (DBVT) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-04-23 Upgrade Societe Generale Hold → Buy
Dec-16-22 Downgrade Goldman Neutral → Sell
May-10-22 Downgrade Goldman Buy → Neutral
Sep-14-21 Upgrade Societe Generale Hold → Buy
Jan-22-21 Downgrade Societe Generale Hold → Sell
Nov-02-20 Upgrade Societe Generale Sell → Hold
Aug-06-20 Downgrade Societe Generale Buy → Sell
Aug-05-20 Reiterated H.C. Wainwright Buy
Mar-17-20 Downgrade Stifel Buy → Hold
Jan-09-20 Upgrade Stifel Hold → Buy
Dec-16-19 Initiated Citigroup Buy
Sep-05-19 Resumed Morgan Stanley Equal-Weight
Jun-17-19 Initiated Goldman Buy
Dec-20-18 Downgrade Barclays Overweight → Equal Weight
Dec-20-18 Downgrade BofA/Merrill Buy → Underperform
Dec-20-18 Downgrade Jefferies Buy → Hold
Dec-20-18 Downgrade Stifel Buy → Hold
Oct-31-17 Upgrade Societe Generale Sell → Hold
Oct-24-17 Downgrade Societe Generale Buy → Sell
Oct-23-17 Downgrade Morgan Stanley Overweight → Equal-Weight
Jun-23-17 Initiated Deutsche Bank Buy
Mar-16-17 Upgrade Societe Generale Hold → Buy
Sep-26-16 Initiated JMP Securities Mkt Outperform
Dec-03-15 Initiated Barclays Overweight
Oct-23-15 Initiated BofA/Merrill Buy
View All

Dbv Technologies Adr Stock (DBVT) Latest News

pulisher
Nov 16, 2024

StockNews.com Begins Coverage on DBV Technologies (NASDAQ:DBVT) - Defense World

Nov 16, 2024
pulisher
Nov 14, 2024

DBV Technologies (NASDAQ:DBVT) Earns Hold Rating from Analysts at StockNews.com - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

DBV Technologies Stock to Reverse Split on Friday, November 29th (NASDAQ:DBVT) - Defense World

Nov 13, 2024
pulisher
Nov 13, 2024

DBV Technologies Stock Set to Reverse Split on Friday, November 29th (NASDAQ:DBVT) - MarketBeat

Nov 13, 2024
pulisher
Nov 11, 2024

DBV Technologies Announces Plan to Implement ADS Ratio Change - The Manila Times

Nov 11, 2024
pulisher
Nov 11, 2024

DBV Technologies Plans 1:5 ADS Ratio Change to Meet Nasdaq Requirements | DBVT Stock News - StockTitan

Nov 11, 2024
pulisher
Nov 07, 2024

DBV Technologies’ stock slides as financial woes worsens - Pharmaceutical Technology

Nov 07, 2024
pulisher
Nov 06, 2024

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading - MSN

Nov 06, 2024
pulisher
Nov 06, 2024

DBV Technologies Reports Third Quarter 2024 Financial Results - GlobeNewswire

Nov 06, 2024
pulisher
Nov 06, 2024

DBV Technologies (NASDAQ:DBVT) Stock Price Passes Above 50 Day Moving AverageTime to Sell? - MarketBeat

Nov 06, 2024
pulisher
Nov 06, 2024

DBV Technologies (NASDAQ:DBVT) Now Covered by Analysts at StockNews.com - Defense World

Nov 06, 2024
pulisher
Nov 01, 2024

European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - MSN

Nov 01, 2024
pulisher
Oct 30, 2024

European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading - MSN

Oct 30, 2024
pulisher
Oct 30, 2024

European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading - MSN

Oct 30, 2024
pulisher
Oct 29, 2024

DBV Technologies (NASDAQ:DBVT) Research Coverage Started at StockNews.com - Defense World

Oct 29, 2024
pulisher
Oct 29, 2024

DBV Technologies (NASDAQ:DBVT) Receives New Coverage from Analysts at StockNews.com - MarketBeat

Oct 29, 2024
pulisher
Oct 26, 2024

European Equities Traded in the US as American Depositary Receipts Gain Wednesday - MSN

Oct 26, 2024
pulisher
Oct 26, 2024

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading - MSN

Oct 26, 2024
pulisher
Oct 26, 2024

European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading - MSN

Oct 26, 2024
pulisher
Oct 26, 2024

HC Wainwright Forecasts Higher Earnings for DBV Technologies - Defense World

Oct 26, 2024
pulisher
Oct 26, 2024

European Equities Traded in the US as American Depositary Receipts Rise Slightly Higher in Thursday Trading - MSN

Oct 26, 2024
pulisher
Oct 25, 2024

European Equities Traded in the US as American Depositary Receipts Nudge Lower in Monday Trading - MSN

Oct 25, 2024
pulisher
Oct 25, 2024

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading - MSN

Oct 25, 2024
pulisher
Oct 25, 2024

Data-Based Insights About DBV Technologies ADR (DBVT) - Stocks Register

Oct 25, 2024
pulisher
Oct 25, 2024

HC Wainwright Has Positive Forecast for DBVT FY2024 Earnings - MarketBeat

Oct 25, 2024
pulisher
Oct 25, 2024

GSK Plc ADR (GSK): An Important Analyst Insights - Stocks Register

Oct 25, 2024
pulisher
Oct 25, 2024

Paramount Global (NASDAQ: PARA): Blank Check On Growth? - Stocks Register

Oct 25, 2024
pulisher
Oct 25, 2024

European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Friday Trading - MSN

Oct 25, 2024
pulisher
Oct 25, 2024

H.C. Wainwright raises DBV Technologies shares price target, keeps Buy rating - Investing.com India

Oct 25, 2024
pulisher
Oct 24, 2024

DBV Technologies (NASDAQ:DBVT) PT Raised to $7.00 - MarketBeat

Oct 24, 2024
pulisher
Oct 24, 2024

The United States Allergy Immunotherapy Market Size & Outlook, 2027 - Grand View Research

Oct 24, 2024
pulisher
Oct 23, 2024

DBV Technologies ADR (NASDAQ: DBVT) Is The Number One Stock Currently Moving. - Stocks Register

Oct 23, 2024
pulisher
Oct 23, 2024

Atlantic Union Bankshares Corp Still Hasn’t Convinced Analysts? - Stocks Register

Oct 23, 2024
pulisher
Oct 22, 2024

DBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the United States and Europe - GlobeNewswire

Oct 22, 2024
pulisher
Oct 21, 2024

DBV Technologies (NASDAQ:DBVT) Coverage Initiated by Analysts at StockNews.com - Defense World

Oct 21, 2024
pulisher
Oct 19, 2024

DBV Technologies to Participate in Upcoming ACAAI 2024 Congress - The Manila Times

Oct 19, 2024
pulisher
Oct 18, 2024

DBV Technologies S.A. - Via Ritzau

Oct 18, 2024
pulisher
Oct 16, 2024

Peanut Protein Patch Market Report to 2032 -DBV Technologies, Segment - IndiaPolitics.com

Oct 16, 2024
pulisher
Oct 09, 2024

DBV Technologies SA (DBVT) (Q2 2024) Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance

Oct 09, 2024
pulisher
Oct 09, 2024

European Equities Traded in the US as American Depositary Receipts Tread Water in Wednesday Trading - MSN

Oct 09, 2024
pulisher
Oct 07, 2024

European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading - MSN

Oct 07, 2024
pulisher
Oct 04, 2024

Point72 Asset Management L.P. Cuts Stock Position in DBV Technologies S.A. (NASDAQ:DBVT) - MarketBeat

Oct 04, 2024

Dbv Technologies Adr Stock (DBVT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Dbv Technologies Adr Stock (DBVT) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Mohideen Pharis
Chief Medical Officer
May 24 '24
Sale
1.36
660
898
81,152
Mohideen Pharis
Chief Medical Officer
May 22 '24
Sale
1.38
382
527
81,812
Tasse Daniel
CHIEF EXECUTIVE OFFICER
Mar 08 '24
Buy
0.83
17,094
14,188
17,094
Ndu Adora
Director
Feb 06 '24
Buy
0.89
1,825
1,624
1,825
Mohideen Pharis
Chief Medical Officer
Nov 22 '23
Sale
1.74
2,245
3,906
82,194
$18.94
price up icon 3.39%
$75.94
price down icon 0.01%
$39.03
price up icon 6.21%
$360.25
price down icon 0.96%
$187.60
price down icon 1.35%
$99.70
price down icon 0.06%
Cap:     |  Volume (24h):